Conflict of interest DK has received research support from Sanofi, Tanabe Pharma, Terumo, Behringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Ono Pharmaceutical and Takeda Pharmaceutical as well as speaker honoraria from Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical
Why Contrave Remains a Valuable Option Even though newer medications like GLP-1 agents have gained significant attention, Contrave continues to play an important role in modern medical weight management
When should I adjust my GLP-1 medication dosage
The Bioavailability Challenge One of the most common misconceptions in wellness is that taking a supplement automatically means your body is using it
Making more dietary changes or intensifying your workouts can help, as can switching from semaglutide to tirzepatide